Headlamp Health today announced the launch of Lumos AI®, a comprehensive decision-support platform designed to help drug developers address the complexity that has long stalled neuroscience progress.

Clover, the all-in-one commerce solution from Fiserv , a leading global provider of payments and financial services technology, today announced a collaboration with Wink, the multimodal biometric ...

Parkinson's disease is no longer viewed as a faraway neurological ailment buried in textbooks. More than 10 million people are already affected worldwide, and the number is continually climbing. Men ...

Teal Health, a virtual women's health company on a mission to eliminate cervical cancer in the U.S., today announced the ...

Today’s hearing aids aren’t great at determining which sounds to amplify and which to ignore, and this often leaves users ...

U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second ...

Researchers say the innovation, known as SmartEM, will speed scanning sevenfold and open the field of connectomics to a broader research community, boosting our understanding of brain function and ...

An evidence-based web-app helped children with epilepsy to fall asleep on average 16.5 minutes earlier. A new UK-wide ...